semaglutide and vision issues Eye Risks of Ozempic: What You Need to Know About NAION Eye Risks of Ozempic: What You Need to Know About Semaglutide and NAION Ozempic Blindness: Should You Worry?

Big news starting July 1

As GLP-1 weight-loss drug costs surge, most Connecticut employers cover them but impose conditions like prior authorization and lifestyle requirements to manage expenses, a strategy the state employee plan has used to slow spending growth.

Research that includes diverse populations, especially women over 40

Here are 6 reliable and gentle ways to reduce GLP-1 constipation FAST.

The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for the treatment of obesity

Obesity has escalated into a global epidemic, with over 1 billion individuals affected worldwide, including nearly 880 million adults and 159 million children and adolescents aged 519 years (World Obesity Federation)